Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

iQ-solutions

K-Number: K231929 · 2023-12-18

ApplicantSydney Neuroimaging Analysis Centre Pty, Ltd.
Decision Date2023-12-18
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

iQ-solutions is a medical device manufactured by Sydney Neuroimaging Analysis Centre Pty, Ltd.. It received FDA 510(k) clearance on 2023-12-18 under approval number K231929. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the iQ-solutions?

iQ-solutions is a medical device that received FDA 510(k) clearance on 2023-12-18. It is manufactured by Sydney Neuroimaging Analysis Centre Pty, Ltd.. The 510(k) number is K231929.

When was iQ-solutions approved by the FDA?

iQ-solutions received FDA 510(k) clearance on 2023-12-18, under approval number K231929.

What company makes iQ-solutions?

iQ-solutions is manufactured by Sydney Neuroimaging Analysis Centre Pty, Ltd..

What is the FDA product code for iQ-solutions?

The FDA product code for iQ-solutions is QIH.

Related Devices (Code: QIH)

K191647QLAB Advanced Quantification SoftwarePhilips Health Care K191171EchoGo CoreUltromics, Ltd. K201195syngo.via MI Workflows, syngo MBFSiemens Medical Solutions USA, Inc. K202013WRDensity by Whiterabbit.aiWhiterabbit.Ai, Inc. K202546LVivo SeamlessDia Imaging Analysis, Ltd. K193283AI-Rad Companion Prostate MRSiemens Medical Solutions USA, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑